TB-500 10mg

TB-500 10mg

$167.00

TB-500, also known as Thymosin Beta-4, is a synthetic version of a naturally occurring 43-amino acid peptide present in nearly all human and animal cells. It plays a critical role in tissue repair and regeneration by promoting cell migration, reducing inflammation, and upregulating actin, a key protein involved in cell structure and movement. TB-500 has shown promise in accelerating the healing of muscle tears, ligament sprains, and tendinitis. Additionally, it is particularly effective in stimulating the formation of new blood vessels and enhancing overall wound healing, making it a valuable tool in regenerative therapies.

Category:

Description

Referenced Citations

  1. Goldstein, A.L., et al. (2012). “Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.” Expert Opinion on Biological Therapy, 12(1), 37-51. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/22074294/
  2. Philp, D., et al. (2003). “Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development.” Mechanisms of Development, 120(12), 1335-1347. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/14623443/
  3. Sosne, G., et al. (2007). “Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury.” Experimental Eye Research, 84(2), 278-286. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/17094961/
  4. Xiong, Y., et al. (2012). “Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.” Annals of the New York Academy of Sciences, 1270, 51-58. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547647/
  5. Su, L., et al. (2022). “Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells.” Stem Cell Research & Therapy, 13(1), 13. [Online].
    Available:https://stemcellres.biomedcentral.com/articles/10.1186/s13287-021-02687-x
  6. Stark, C., et al. (2016). “Thymosin beta 4 treatment improves left ventricular function after myocardial infarction and is related to up-regulation of chitinase 3-like-1 in mice.” Translational Medicine Communications, 1, 8. [Online].
    Available: https://transmedcomms.biomedcentral.com/articles/10.1186/s41231-016-0008-y
  7. Crockford, D., et al. (2010). “Thymosin β4: structure, function, and biological properties supporting current and future clinical applications.” Annals of the New York Academy of Sciences, 1194, 179-189. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/20536467/
  8. Bock-Marquette, I., et al. (2004). “Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.” Nature, 432(7016), 466-472. [Online].
    Available:https://pubmed.ncbi.nlm.nih.gov/15565145/

Related products